Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|September 8, 2007
Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitorsJohn S Wai, Boyoung Kim, Thorsten E Fisher, et al.Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexantIzzat T Raheem, Michael J Breslin, Joseph Bruno, et al.Bioorganic & Medicinal Chemistry|July 28, 2006
Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stabilityDonnette D Staas, Kelly L Savage, Vanessa L Sherman, et al.Bioorganic & Medicinal Chemistry Letters|September 28, 2010
Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffoldPeter D Williams, Donnette D Staas, Shankar Venkatraman, et al.Bioorganic & Medicinal Chemistry Letters|July 29, 2008
10-Hydroxy-7,8-dihydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-diones: potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutantsCatherine M Wiscount, Peter D Williams, Lekhanh O Tran, et al.Journal of Medicinal Chemistry|May 28, 2004
Discovery and evaluation of potent P1 aryl heterocycle-based thrombin inhibitorsMary Beth Young, James C Barrow, Kristen L Glass, et al.Journal of Medicinal Chemistry|April 2, 2005
9-hydroxyazafluorenes and their use in thrombin inhibitorsKenneth J Stauffer, Peter D Williams, Harold G Selnick, et al.ACS Medicinal Chemistry Letters|December 21, 2017
Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease InhibitorsChristopher J Bungard, Peter D Williams, Jurgen Schulz, et al.ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.Journal of Medicinal Chemistry|February 7, 2003
Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridinesChristopher S Burgey, Kyle A Robinson, Terry A Lyle, et al.Pageof 2